Clinical trial
Combination Chemotherapy in Treating Patients With Lymphoma
NCT00002835 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002835 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Lymphoma |
| Official title | A Randomized Prospective Study of Early Intensification Versus Alternating Triple Therapy for Patients With Poor Prognosis Lymphoma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | Bleomycin Sulfate (BLM), Filgrastim (G-CSF), Recombinant Interferon Alfa, Carmustine, Cisplatin (CDDP), Cyclophosphamide, Cytarabine (ARA-C), Etoposide (VP-16), Idarubicin, Ifosfamide and 8 more |
| Enrollment | 116 |
| Start date | Oct 30, 1995 |
| Primary completion | Feb 4, 2004 |
| Completion | Feb 4, 2004 |
| First posted | Apr 16, 2003 |
| Last update posted | Nov 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: